ST
SGYP

Spot Trading’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Spot Trading’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$3K Sell
1,200
-4,000
-77% -$13.6K ﹤0.01% 3006
2017
Q2 		$23K Buy
5,200
+2,500
+93% +$10.3K ﹤0.01% 2981
2017
Q1 		$13K Sell
2,700
-12,600
-82% -$73.1K ﹤0.01% 2725
2016
Q4 		$93K Buy
15,300
+300
+2% +$1.57K 0.02% 2237
2016
Q3 		$83K Sell
15,000
-10,000
-40% -$46.8K 0.01% 2475
2016
Q2 		$95K Buy
+25,000
New +$84.7K 0.01% 2550
2015
Q3 		– Sell
-28,000
Closed -$232K – 4783
2015
Q2 		$232K Buy
28,000
+12,900
+85% +$62.5K 0.01% 2619
2015
Q1 		$70K Buy
+15,100
New +$49.1K ﹤0.01% 3213
2014
Q4 		– Sell
-700
Closed -$2K – 4786
2014
Q3 		$2K Buy
+700
New +$2.54K ﹤0.01% 4217

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return